Growing Cannabis Market: M&A Activity Plays Key
Role; Fourth Preview of Cannabis/ Hemp Stock Directory Released
Investorideas.com – February
8, 2017 – Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks, releases its fourth excerpt of its cannabis
/hemp stock directory for investors following the high profile sector.
Grand View Research
says “The growing number of mergers and acquisitions in the medical cannabis
industry is one of the key attributes that is expected to boost the market over
the coming few years. Some of the recent M&A activities in 2016 are as
follows: • Nexus Corporation was
acquired by Gibraltar Industries, Cannabase entered into a partnership with
BioTrackTHC. ”
More info on recent
M&A activity in the sector - Viridian
Cannabis Deal Tracker for Week Ended 2/3/2017
U.S. medical marijuana market by application, 2013 - 2025
(USD Billion)
Marijuana/Hemp Stock List 2017
Directory Preview: Get the full
list as a member at the Cannabis Directory page: http://www.investorideas.com/Marijuana-Stocks/Stocks_List.asp
NEUTRA CORPORATION (OTC:NTRR) is a
healthy lifestyle company that specializes in the development and marketing of
natural wellness solutions, including cannabis-related products.
New Age Farm Inc. (CSE: NF; OTC: NWGFF) is in the business of providing fully built out
turnkey farming solutions for growers of high value luxury crops. We have
operations in Washington State and British Columbia and are interested in
bringing our innovative model to other jurisdictions with legalized medical
and/or recreational marijuana.
Next
Generation Management Corp (OTC:NGMC) focuses, primarily, on the acquisition of retail
and cultivation licenses in the medical marijuana industry. The Company’s
overarching strategy is to acquire lines of business that have high intrinsic
future value and to generate existing, reliable revenue streams, with the
medical marijuana industry being its most recent and promising direction. With
this expanded direction, the Company has formed a wholly owned subsidiary,
NextGen Cannabis Consulting LLC to provide management services to the high
growth, high profit medical marijuana industry. NextGen Cannabis Consulting is
intent on the development of a national brand that encompasses every aspect of
the medical marijuana industry, including collectives, dispensaries, and
grow-ops. NextGen Holdings, LLC: Next Generation Management Corporation's
wholly-owned subsidiary was formed to hold its Oregon cannabis assets.
Northsight Capital Inc. (OTC:NCAP) is comprised of a portfolio of online marijuana-related
websites that are being developed and operated by the company. These sites
incorporate many aspects of the marijuana industry. The company provides its
audience with a means to stay informed on the industry's most cutting edge
marijuana-related innovations and legislation. The company's most dynamic
concept, WeedDepot.com, provides consumers with a geo-targeted map directory of
medical and recreational dispensaries, head shops, doctors, attorneys and more
within the marijuana industry. The Weed Depot app can be downloaded for free at
the iTunes Store and Google Play. Weed Depot has an entire platform of content
suited for every aspect of advertising and marketing to consumers from all
businesses in the cannabis industry. Northsight's
current websites include: www.Weeddepot.com, www.420careers.com, www.MJBizwire.com, www.MarijuanaRecipes.com, www.RateMyStrain.com, www.WikiWeed.com, www.MarijuanaMd.com, and www.MarijuanaHealthTips.com
Notis Global, Inc (OTC:NGBL) Based in Los Angeles, Notis Global is a pioneer in the burgeoning,
multi-billion dollar legal hemp industry. The Company and its partners are
working to grow confidence and generate revenues in the hemp industry. Through
our key partnership with Folium Biosciences, one of the largest hemp operations
in the U.S., Notis is a leading provider and distributor of cannabidiol (CBD).
NOVUS Acquisition & Devleopment Corp. (OTC:NDEV) provides
health insurance and related insurance solutions to the medical marijuana
industry in states where legal programs exist. The Company also plans to offer
physicians' education programs, pharmaceutical R&D, compliance, and
business development services within the industry.
Nutritional High International Inc. (CSE:EAT; OTCQB:SPLIF; FRANKFURT:2NU.F) is focused on developing, manufacturing and distributing products and
nationally recognized brands in the hemp and marijuana-infused products
industries, including edibles and oil extracts for nutritional, medical and
adult recreational use. The Company works exclusively through licensed
facilities in jurisdictions where such activity is permitted and regulated by
state law.
Omnicanna Health (formerly Endocan) (OTC:ENDO) is
currently developing new natural cannabis-based products based on innovative
formulations to utilize the unique and potent benefits of the cannabis and hemp
plants. Medicinal properties of cannabis and hemp have been known and applied
for thousands of years. With the aid of scientific research, OmniCanna Health
Solutions is translating such knowledge into development of effective
cannabinoid formulation-based health and wellness solutions as well as
cosmeceutical, nutraceutical, and food brands throughout the world. The
Company's health and wellness, nutritional, and cosmetics lines will address
personal needs and will evolve with the introduction of new formulations and products,
advancing the Company within the expanding multibillion-dollar global market.
OrganiGram Holdings Inc. (TSX:OGI.V)
wholly owned subsidiary, Organigram Inc., is a
licensed producer of medical marijuana in Canada. Organigram is focused on
producing the highest quality, condition specific medical marijuana for
patients in Canada. Organigram's facility is located in Moncton, New Brunswick
and the Company is regulated by the Marihuana for Medical Purposes Regulations.
OWC Pharmaceutical Research Corp. (OTC:OWCP) through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd.,
(collectively \"OWC\" or the \"Company\") conducts medical
research and clinical trials to develop cannabis-based pharmaceuticals and
treatments for conditions including multiple myeloma, psoriasis, fibromyalgia,
PTSD, and migraines. OWC is also developing unique delivery systems for the
effective delivery and dosage of medical cannabis. All OWC research is
conducted at leading Israeli hospitals and scientific institutions, and led by
internationally renowned investigators. The Company's Research Division is
focused on pursuing clinical trials evaluating the effectiveness of
cannabinoids for the treatment of various medical conditions, while its
Consulting Division is dedicated to helping governments and companies navigate
complex international cannabis regulatory frameworks.
Pazoo, Inc. (OTC:PZOO) is a company focused on health,
wellness and safety. Our focus is to provide best-in-class laboratory testing
of cannabis and cannabinoids to
protect consumers from impurities, contaminants and other irregularities.
Through our wholly owned subsidiary, Harris Lee, and our partnership with MA
& Associates, Pazoo provides industry leading laboratory testing of
cannabis. Pazoo's license agreement with Steep Hill Labs Inc. allows us to use
their best-in-market testing protocols on a right of first refusal basis as we
expand throughout the USA. Pazoo is licensed to test cannabis in Nevada and
Oregon, with a focus on expansion into other states. Additionally, Pazoo
delivers a comprehensive array of health and wellness information on its
website www.pazoo.com, and features industry experts from both the health and wellness arena
and the pet industry.
Pharmacyte Bioetch (OTC:PMCB) (Formerly Nuvilex, Inc) is a clinical stage biotechnology company focused on developing and
preparing to commercialize treatments for cancer and diabetes based upon a
proprietary cellulose-based live cell encapsulation technology known as
Cell-in-a-Box® This unique and patented technology
will be used as a platform upon which treatments for several types of cancer,
including advanced, inoperable pancreatic cancer, and diabetes are being built.
PharmaCyte Biotech's treatment for pancreatic cancer involves low doses of the
well-known anticancer prodrug ifosfamide, together with encapsulated live
cells, which convert ifosfamide into its active or "cancer-killing"
form. These capsules are placed as close to the cancerous tumor as possible to
enable the delivery of the highest levels of the cancer-killing drug at the
source of the cancer. This "targeted chemotherapy" has proven
remarkably effective in past clinical trials. In addition, PharmaCyte Biotech
is working towards improving the quality of life for patients with advanced
pancreatic cancer and on treatments for other types of solid cancerous tumors.
PharmaCyte Biotech is also developing treatments for cancer based upon chemical
constituents of marijuana known as cannabinoids. In doing so, PharmaCyte
Biotech is examining ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness
of cannabinoids, while minimizing or outright eliminating the debilitating side
effects usually associated with cancer treatments. This provides PharmaCyte
Biotech the rare opportunity to develop "green" approaches to
fighting deadly diseases, such as cancer of the pancreas, brain and breast,
which affect hundreds of thousands of individuals worldwide every year.
Pineapple Express Inc. (OTC:PNPL) Headquartered in Los Angeles, Calif., Pineapple
Express is a publicly traded company that invests in, expands, and brands
existing and newly established canna-businesses through expert consulting and
cutting-edge technology. We provide capital to our canna- business clientele,
lease real properties to canna-businesses, and provide consulting and
technology to operators within the cannabis industry. We intend to create a
nationally branded chain of company owned cannabis retail stores under the
"Pineapple Express" name, as soon as federal laws allow. As long as
cannabis remains federally illegal our operations will be limited to
consulting, product licensing, leasing to and investing in existing and new
canna-businesses, selling industry specific technology, and branding/retail
concept support services. Home to some of the most experienced and
well-connected minds in the business, Pineapple Express is at the forefront of
the legal cannabis industry.
Plandaí Biotechnology, Inc. (OTC:PLPL) and its
subsidiaries develop highly bioavailable, phytonutrient rich extracts which are
being utilized to deliver a new family of drugs to safely and affordably treat
a multitude of diseases and conditions. Plandaí Biotechnology controls every
aspect of the process, from growing the raw materials on its farms in South
Africa, to producing its proprietary Phytofare™ extracts in-house, allowing the
Company to guarantee the continuity of supply as well as quality control
throughout the entire process. Targeted industries for the Company's products
include beverage, cosmeceutical, wellness, nutriceutical, anti-aging, and
pharmaceutical.
Players Network Inc (OTC:PNTV) is a diversified company with holdings in Media
and Medical Marijuana. The Company uses its proprietary Enterprise Web Platform
to develop Branded Digital Lifestyle Television Networks for itself and its
partners in a wide range of lifestyle categories. Player's Network's current
original channels, "Player's Network," "Vegas on Demand,"
"Real Vegas TV," focus on the Las Vegas and Gaming Lifestyles. These
channels are distributed over PNTV's owned and operated VOD Channels over its
Broadband Network and Mobile Platforms. The Medical Marijuana assets are
primarily through the Company's 86% ownership in Greenleaf Farms Holdings, and
PNTV's newest channel, WeedTV.com, which focuses
on the rapidly expanding cannabis community.
Profile Solutions, Inc. (OTC:PSIQ) designs, manufactures and sells security-based
identification products and systems that incorporate state-of-the-art security
technology to verify a person's identity, or grant physical access. PSI has
developed turnkey integrated applications that incorporate our proprietary
Access-It hardware platform. We also integrate our applications with
biometric technology for additional security when required. PSI targets the law
enforcement, cannabis industry and
corporate America as our customer base.
PUF Ventures Inc. (CSE:PUF) is moving into the Medical Marijuana sector by purchasing a 100%
interest in AAA Heidelberg, a private Ontario company that is in the process of
applying for a MMPR license. Although the Company cannot guarantee nor estimate
the timing for the issuance of a license to AAA Heidelberg, it is PUF’s goal to
become the next publicly traded Canadian company to be granted a new medical
marijuana production license. VapeTronix, a wholly owned subsidiary of the
Company, is in the process of expanding its 1313 brand of electronic cigarettes
and associated technologies.
Puget Technologies, Inc. (OTC: PUGE) is a development-stage company. The Company is engaged in developing and
marketing of consumer-oriented products ready for commercialization. The
Company's subsidiaries include B-29 Energy, Inc. (B-29), which is in the
development stage. B-29 is engaged in the business of development and
distribution of energy products. B-29's products include B-29 Energy Drink and
various medical marijuana products, which are under development. B-29 produces
these products through its subsidiary, Cannabis Biotech. The Company is also
engaged in the development of three dimensional (3D) printing and supporting
technologies for My3DP personal printer. The applications of the Company's
products are in various sectors, which include crafting, jewelry and domestic
goods.
Radient Technologies Inc. (TSX:RTI.V) extracts natural compounds from a range
of biological materials using microwave assisted processing ("MAP™"),
a patented technology platform which provides superior customer outcomes in
terms of ingredient purity, yield, and cost. From its 20,000 square foot
manufacturing plant in Edmonton, Alberta, Radient serves market leaders in
industries that include pharmaceutical, food, beverage, natural health,
personal care and biofuel markets. Marijuana
– November 14 press release
announces foray in the fast emerging cannabinoids medical market.
Rapid Fire Marketing, Inc. (OTC:RFMK) is a developer
and reseller of herbal vaporizers. The core strategy is to maximize revenues in
the rapidly expanding medical cannabis and vaporizer industries. Rapid Fire
Marketing also looks to invest and do joint ventures with companies in the
vaporizer and medical cannabis industries as well as working with other
companies with established revenue streams that are looking to grow their
businesses. Rapid Fire Marketing is also looking to grow through acquisitions
of companies or technologies that are synergistic with our business plan.
RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) is a leader in the development of medicines for
respiratory disorders, with a focus on sleep apneas and drug-induced respiratory
depression. The Company holds exclusive licenses and owns patents and patent
applications or rights thereto for certain families of chemical compounds that
claim the chemical structures and their uses in the treatment of a variety of
disorders, as well as claims for novel uses of known drugs. RespireRx has a
pipeline of medicines in Phase 2 clinical development focused on pharmaceutical
treatments for a variety of breathing disorders. Clinical development in the
area of respiratory disorders, particularly drug-induced respiratory depression
and sleep apnea, has created opportunities for the development and
commercialization of the Company's compounds. Cannabinoids. One platform being developed by RespireRx is the
class of compounds known as cannabinoids, including dronabinol. Under a license
agreement with the University of Illinois, the Company has rights to patents
claiming the use of cannabinoids for the treatment of sleep-related breathing
disorders. Ampakines. The other platform of proprietary medicines being
developed by RespireRx are ampakines, which act to enhance the actions of the
excitatory neurotransmitter glutamate at AMPA glutamate receptors. Several
ampakines, in both oral and injectable forms, are being developed by the
Company for the treatment of a variety of breathing disorders. In clinical
studies, select ampakines have shown preliminary efficacy in central sleep
apnea and in the control of respiratory depression produced by opioids, without
altering the opioid analgesic effects. In animal models of orphan disorders,
such as Pompe Disease, spinal cord injury and perinatal respiratory distress,
it has been demonstrated that certain ampakines improve breathing function. The
Company's compounds belong to a new class that does not display the undesirable
side effects previously reported for other ampakines.
Rocky Mountain
High Brands Inc (OTC:RMHB) is a consumer
goods company specializing in brand development of health conscious,
hemp-infused food and beverage products. The Company currently markets a lineup
of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea,
Mango Energy and Lemonade) and a low-calorie Coconut Lime Energy drink. Rocky
Mountain High Brands also offers hemp-infused 2oz. Mango Energy Shots and Mixed
Berry Energy Shots, as well as a new Relaxation Brownie. The Company recently
launched a naturally high alkaline spring water, Eagle Spirit Spring Water™.
Get the full list as a member at the Cannabis Directory page: http://www.investorideas.com/Marijuana-Stocks/Stocks_List.asp
This directory is for research purposes and not a solicitation to buy or
sell securities.
To be added to the directory or update your description, please call or
email us.
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Sectors we cover in
include tech, bitcoin and blockchain , biotech, mining, energy, renewable
energy, water stocks, marijuana and hemp stocks, food and beverage (including
organic and LOHAS, wine), defense and security including biometrics, Latin America,
sports, entertainment, luxury brands and gaming.
Follow stocks in your
favourite stock sector including marijuana and hemp stocks with Investor Ideas
stock directories
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. PSIQ is a paid PR
and news client on Investorideas – more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Contact Investorideas.com
800-665-0411
Marijuana / Hemp Stocks
Global Cannabis Investing - features Investor Ideas Cannabis news
No comments:
Post a Comment